Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathew Cherian

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 22, 2023
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patientsAbena Minta, Lucy Rose, Candice Park, et al.
Investigational New Drugs|January 16, 2020
Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experienceAnupama Suresh, Akannsha Ganju, Evan Morgan, et al.
NPJ Breast Cancer|June 19, 2024
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancerKai C C Johnson, Ai Ni, Dionisia Quiroga, et al.
Clinical Breast Cancer|June 20, 2025
Changes in Glucose level During Chemotherapy Treatment in Patients With Stage I-IV Breast CancerPatrick M Schnell, Mahmoud Kassem, Abdul Miah, et al.
Investigational New Drugs|January 19, 2020
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Mohamed Badawi, Ewa Mrozek, et al.
NPJ Breast Cancer|March 22, 2022
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysisJairam Krishnamurthy, Jingqin Luo, Rama Suresh, et al.
European Journal of Breast Health|July 14, 2020
Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female ControlsJoseph Liu, Anupama Suresh, Marilly Palettas, et al.
Breast Cancer Research and Treatment|September 9, 2021
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancerJasmine S Sukumar, Dionisia Quiroga, Mahmoud Kassem, et al.
ERJ Open Research|April 26, 2021
Dyspnoea and symptom burden in mild-moderate COPD: the Canadian Cohort Obstructive Lung Disease StudyMathew Cherian, Dennis Jensen, Wan C Tan, et al.
Therapeutic Advances in Medical Oncology|June 12, 2025
Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysisDionisia Quiroga, Charles Pei, Julie A Stephens, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 22, 2023
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patientsAbena Minta, Lucy Rose, Candice Park, et al.
Investigational New Drugs|January 16, 2020
Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experienceAnupama Suresh, Akannsha Ganju, Evan Morgan, et al.
NPJ Breast Cancer|June 19, 2024
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancerKai C C Johnson, Ai Ni, Dionisia Quiroga, et al.
Clinical Breast Cancer|June 20, 2025
Changes in Glucose level During Chemotherapy Treatment in Patients With Stage I-IV Breast CancerPatrick M Schnell, Mahmoud Kassem, Abdul Miah, et al.
Investigational New Drugs|January 19, 2020
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Mohamed Badawi, Ewa Mrozek, et al.
NPJ Breast Cancer|March 22, 2022
A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysisJairam Krishnamurthy, Jingqin Luo, Rama Suresh, et al.
European Journal of Breast Health|July 14, 2020
Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female ControlsJoseph Liu, Anupama Suresh, Marilly Palettas, et al.
Breast Cancer Research and Treatment|September 9, 2021
Patient preferences and adherence to adjuvant GnRH analogs among premenopausal women with hormone receptor positive breast cancerJasmine S Sukumar, Dionisia Quiroga, Mahmoud Kassem, et al.
ERJ Open Research|April 26, 2021
Dyspnoea and symptom burden in mild-moderate COPD: the Canadian Cohort Obstructive Lung Disease StudyMathew Cherian, Dennis Jensen, Wan C Tan, et al.
Therapeutic Advances in Medical Oncology|June 12, 2025
Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysisDionisia Quiroga, Charles Pei, Julie A Stephens, et al.
Pageof 13